BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:albuterol (Armstrong Albuterol HFA) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of albuterol (Armstrong Albuterol HFA)\, fro
 m ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07426458-4182@assetmemo.bio
DTSTAMP:20261121T010015Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:albuterol (Armstrong Albuterol HFA): Phase 4 readout est. (NCT07426
 458)
DESCRIPTION:albuterol (Armstrong Albuterol HFA)\, phase 4\, Asthma.\nStudy:
  Ventilation and Perfusion in Asthmatics\nEstimated primary completion: Ap
 ril 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/albuterol-a
 rmstrong-albuterol-hfa#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07426458
URL:https://assetmemo.bio/drug/albuterol-armstrong-albuterol-hfa#upcoming-e
 vents
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
